Dubinsky, Marla MD
Icahn School of Medicine at Mount Sinai Hospital | New York, USA
Marla C. Dubinsky received her medical degree from Queen’s University in Canada and completed her clinical pediatric gastroenterology training at Sainte-Justine Hospital, University of Montreal in Quebec, Canada. Currently, Dr. Dubinsky is Chief of Pediatric Gastroenterology, Hepatology & Nutrition, Co-Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center and Professor of Pediatrics and Medicine at the Icahn School of Medicine at Mount Sinai Hospital in New York.
Escher, Johanna MD PhD
Erasmus Medical Center – Sophia Children’s Hospital | Rotterdam, The Netherlands
Professor Johanna (Hankje) Escher (1963) is a Pediatric Gastroenterologist and is Head of the Pediatric Gastroenterology Department of the Erasmus MC-Sophia Children’s Hospital in Rotterdam, The Netherlands. Her research focus is on pediatric Inflammatory Bowel Disease (PIBD), with publications on disease phenotype, treatment and transition. Professor Escher is the initiator of EUROKIDS, a multicenter European prospective PIBD registry. She has chaired the Porto IBD working group of ESPGHAN (2007-2001), was a frontline P-ECCO committee member (2010-2013) and is now an active member of the Porto IBD working group of ESPGHAN and member of the operational board of PIBD-net. Prof. Escher has authored over 100 international publications concerning pediatric IBD. She is currently working on biomarkers of anti-TNF treatment response in pediatric and adult IBD, the effect of cognitive behavioral treatment in pediatric and adult IBD, and the outcome of transitional care.
Griffiths, Anne MD
The Hospital for Sick Children | Toronto, Canada
Dr. Anne Griffiths is Professor of Paediatrics at the Hospital for Sick Children, University of Toronto, where she holds the Northbridge Chair in IBD and co-leads the IBD Centre. She is Principal Investigator of the Canadian Children IBD network, involving 12 paediatric IBD centers across Canada. Within the Toronto SickKids IBD program, and as paediatric GI fellowship training program director (1998-2003) and GI Division Head (2008-2015), Dr. Griffiths has mentored and trained many paediatric gastroenterologists, now clinician investigators engaged in IBD clinical care and research across Canada and beyond. Her clinical and translational research interests have included the genetic basis of susceptibility to IBD and paediatric IBD outcomes research. She was responsible as principal investigator for developing the IMPACT questionnaire, a disease-specific health-related quality of life instrument for paediatric IBD and the Paediatric Ulcerative Colitis Activity Index (PUCAI). She has lectured widely nationally and internationally, including recently as the 2016 Visiting Clinical Professor of the Canadian Association of Gastroenterology.
Hyams, Jeffrey MD
CONNECTICUT CHILDREN'S MEDICAL CENTER | CONNECTICUT, USA
M.D. University of Pennsylvania School of Medicine | Resident in Pediatrics, Children's Hospital Boston | Fellow in Medicine, Children's Hospital, Boston | Professor of Pediatrics, University of Connecticut School of Medicine | Head, Division of Digestive Diseases, Hepatology, and Nutrition, Connecticut | Children’s Medical Center, Hartford, CT
Levine, Arie MD
Wolfson Medical Center | Tel Aviv, Israel
Arie Levine is the director of the pediatric gastroenterology and nutrition unit at the Wolfson Medical Center and associate professor at Tel Aviv University, Israel. His clinical and research interests are focused primarily on IBD. Arie has chaired the ESPGHAN Porto group, and PECCO, the pediatric committee of ECCO. He is a founding member of the dietary committee of ECCO. He was instrumental in the classification schemes and diagnostic criteria for pediatric IBD, leading the Paris Classification and Revised Porto criteria for IBD. He also serves as a section editor on the IBD journal. In recent years he has led numerous novel research concepts through clinical and translational studies including early clinical prognostication of IBD, treatment strategies targeting the microbiota in IBD, as well as the role of diet in pathogenesis and treatment of IBD. He is currently running several multicenter multination randomized controlled trials targeting the microbiota.
Martín de Carpi, Javier PhD
President | Hospital Sant Joan de Déu | Barcelona, Spain
Javier Martín de Carpi is Head of Department, Pediatric Gastroenterology, Hepatology and Nutrition at Hospital Sant Joan de Déu, Barcelona and associate Professor at Universitat de Barcelona, Spain. He coordinates the Unit for the Comprehensive Care of Paediatric IBD (UCIEII-P), the biggest pediatric IBD (PIBD) unit in the country. Dr. Martín de Carpi is the author of multiple papers specially focused in pediatric IBD and he is a frequent speaker in different meetings centered in these diseases, as well as an active member of the Spanish Society of Pediatric Gastroenterology and Nutrition (SEGHNP), ESPGHAN and ECCO. <br />
Navas-López, Víctor Manuel PhD
Vice President | Hospital Materno Infantil | Málaga, Spain
Victor Manuel Navas-López, MD, PhD is Consultant at the Pediatric Gastroenterology and Nutrition Unit of Materno Infantil Hospital in Málaga since September 2006. He is member of SEGHNP (Spanish Society of Pediatric Gastroenterology and Nutrition), ESPGHAN (The European Society for Paediatric Gastroenterology Hepatology and Nutrition), ECCO (European Crohn’s and Colitis Organization), GETECCU (the Spanish Medical Association for the Study of Crohn’s Disease and Ulcerative Colitis), AEG (Asociación Española de Gastroenterología) and recently became member of the Porto Group of ESPGHAN.
Panés Díaz, Julià MD PhD
Hospital Clínic | Barcelona, Spain
Dr. Julian Panes is Director of the IBD Unit at Hospital Clínic in Barcelona, and assistant professor of Medicine of the University of Barcelona. His research group is focused on the development and implementation of new diagnostic tools, with special interest in cross-sectional imaging, the identification of new molecular targets for treatment of inflammatory bowel diseases, and the development of cell therapies for treatment of inflammatory bowel diseases. He has published more than 300 manuscripts in international peer-reviewed journals, has served as a member of the Scientific Committee of the United European Gastroenterology Federation, member of the Scientific Committee of European Crohn’s and Colitis organization, member of the board of International Organization for the study of Inflammatory Bowel Disease, member of the Editorial Board of various international publications, Associate Editor of Gut, and he is currently President of ECCO.
Ruemmele, Frank MD PhD
Hôpital Necker-Enfants Malades | Paris, France
Turner, Dan MD PhD
Shaare Zedek Medical Center | Jerusalem, Israel
Since 2008, Dan Turner heads the Juliet Keidan Institute of Pediatric Gastroenterology at Shaare Zedek Medical Center, Jerusalem, and directs its Pediatric inflammatory bowel diseases (IBD) Center. He is a Professor of Pediatrics at The Hebrew University of Jerusalem and the author of over 120 peer-review manuscripts in IBD. He is currently the chair of the Pediatric IBD Porto group of ESPGHAN, vice-president of the international pediatric PIBD-network and an elected member of the International Organization of IBD (IOIBD). He graduated Medical School at Ben Gurion University of the Negev, Israel, in 1999, followed by residency in Pediatrics at Shaare Zedek Medical Center, Jerusalem. He completed his fellowship in pediatric gastroenterology at the Hospital for Sick Children in Toronto. In 2007, he received his PhD in clinical epidemiology from the University of Toronto.
Wilson, David MD
University of Edinburgh Medical School | Edinburgh, UK
Professor of Paediatric Gastroenterology and Nutrition and Honorary Consultant in Paediatric Gastroenterology; Child Life and Health, University of Edinburgh and Department of Gastroenterology and Nutrition, Royal Hospital for Sick Children, Edinburgh. | Profile: David qualified from Queen’s University of Belfast, and following paediatric training in Northern Ireland, including a doctoral thesis, moved to Toronto, in July 1994 to complete his PGHAN training. After this wonderful experience, he returned to the UK upon appointment in Edinburgh in August 1997 and set up the PGHAN service for SE Scotland. David is clinical lead of the PGHAN service in Edinburgh and of the SE Scotland regional PGHAN network, and his main clinical interest is in IBD. David’s programme of academic activities includes clinical, epidemiological and translational research in IBD. He previously chaired the BSPGHAN IBD Working Group, and is an active member of the ESPGHAN Paediatric IBD Porto Group and P-ECCO committee. David has supervised excellent research fellows completing doctorates in IBD, and has authored or co-authored >150 papers in peer-reviewed journals, over 65% of these on IBD.
Wine, Eytan MD PhD
University of Alberta| Alberta, Canada
Dr. Wine is an Associate Professor of Pediatrics and Physiology, Clinician Scientist, and Pediatric Gastroenterologist at the University of Alberta in Canada. After his Medical and Pediatric training in Israel, he completed a Pediatric Gastroenterology Fellowship at the Hospital for Sick Children in Toronto and earned his PhD in Cellular Microbiology at the University of Toronto in Philip Sherman’s laboratory. Dr. Wine’s clinical expertise is managing children with inflammatory bowel diseases (IBD). This interest fits well with his laboratory research focus on involvement of intestinal bacteria in development of intestinal inflammation, enabling translational bench-to- bedside research. Work in the Wine lab is funded by Alberta Innovates- Health Solutions (AIHS), Crohn’s and Colitis Foundation of America (CCFA), and Crohn’s and Colitis Canada (CCC). Dr. Wine is a co-principle applicant on the CIHR-CHILD Foundation Canadian Children IBD Network and is a member of the ESPGHAN Porto IBD Group.